SUMMARY
Two type B15 P1.16 strains of Neisseria meningitidis were examined by immunogold electron microscopy for accessibility of two outer membrane protein (OMPs) to monoclonal antibodies. Both strains exhibited cell-to-cell variation of one epitope of the Class 3 OMP (P3.15) and one of the Class 1 OMPs (PI.16) when grown in vitro. One strain, a nasopharyngeal isolate revealed this variation to be growth-phase independent and double labelling of both epitopes showed independent variation. CSF containing N. meningitidis was stored in liquid nitrogen without laboratory processing at the time of isolation of the second strain. Direct analysis of the organisms showed no cell-to-cell variation and immunoglobulin G on the surface. However, while there were similar labelling densities of the Class 1 epitope in vivo compared with either strain grown in vitro, there was a lower labelling density of the Class 3 epitope in vivo that was not caused by freeze-thawing. This reduction may be due to decreased expression of this epitope in vivo which casts doubt on the use of the Class 2/3 OMP as a vaccine candidate.
INTRODUCTION
Neisseria meningitidis group B is the major cause of meningitis in Europe [1] . Capsular polysaccharide has been used as vaccine for both Groups A and C meningococci [2] , but as that of Group B is non-immunogenic [3] sub-capsular antigens are being investigated. Research is currently focussed on the serotype (Class 2/3) or subserotype (Class 1) proteins.
Immunogold electron microscopy (IGEM) has demonstrated that the accessibility of epitopes of outer membrane proteins (OMPs) [4, 5] or lipooligosaccharide (LOS) [6] to monoclonal antibodies (MAbs) may vary among different cells of the same culture in N. gonorrhoeae. The expression of OMPs of other Gram-negative bacteria also varies according to growth conditions [7] . The accessibility of the Class 2 protein to MAbs for N. menin-gitidis Group B type 2b appears to vary according to the growth phase [8] . In addition nutrient limitation may induce expression of new proteins [9] [10] [11] , it being apparent that growth conditions in vivo differ from those in vitro [12] . We used IGEM to explore the interaction of MAbs with epitopes of the serotype and subserotype protein of two strains of serogroup B15 P1.16 grown in vitro, and compared these interactions with those of organisms examined directly from the cerebrospinal fluid (CSF) of a patient with meningitis who was the source of one of the strains.
MATERIALS AND METHODS

Clinical material
Strain 70942 (B15 P1.16), isolated from the nasopharynx of a young adult with meningitis, and strain R/P/87 (B15 P1.16), isolated from the CSF of a 36-year-old female presenting with meningitis 3 days after the onset of symptoms, were stored at -70 °C in decomplemented horse serum within two passages of isolation. An aliquot of CSF from the second patient was stored in liquid nitrogen without laboratory processing.
Bacterial culture
Bacteria were thawed and passaged on MuEller Hinton (MH) agar with 5% horse blood (BA) overnight at 37°C in 5% CO 2 in air. Preparations for IGEM were grown overnight on BA or for 2, 4, 8 or 16 h in MH broth. BA growth of strain R/P/87 was suspended in 5% bovine serum albumin (A-7030, Sigma) in PBSA (BSA/PBSA) and stored in liquid nitrogen.
Monoclonal antibodies
Mouse ascites fluid MAbs (IgG) to two epitopes of the P3.15 OMP and two to the Pl.16, were used to give maximum labelling at dilutions in BSA/PBSA of 10 2 and 103 for the P3. 15 MAbs and 105 for the P1.16 MAbs.
Gold:probe prepration
Protein A (17-0770-0 Pharmacia) and the following affinity purified antibodies (Nordic Immunological Laboratories) were conjugated to colloidal gold; rabbit anti-mouse IgG (RAM/7S) coupled to 8 nm and 20 nm gold particles (RAMIgG/Au) and rabbit anti-human IgG, IgA and IgM (RAHu/IgG(Fc)/7S, RAHu/ IgA(Fc)/7S, RAHu/IgM(Fc)/7S) coupled to 20 nm gold particles (RAHuIgG, IgA or IgM/Au).
Colloidal gold solutes of 8 nm and 20 nm diameter were prepared by the methods of Mialpfordt [13] and Frens [14] , respectively, and the protein A/gold and antibody/gold conjugates prepared (Janssen handbook).
Lowicryl resin embedding
Bacterial growth from BA was suspended in 3% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2, fixed for 1 h at RT, washed 3 times by centrifugation in phosphate buffer, quenched in 0.5 M ammonium chloride in phosphate buffer for 1 h at RT, re-washed and enrobed in 2% low-gelling temperature agarose (Type VII A-4018, Sigma) in phosphate buffer. The resultant blocks were processed to Lowicryl K4M resin after methanol dehydration [15] , and polymerised under UV light (365 nm) at -30°C for 24 h. Ultrathin sections (LKB III ultramicrotome) were mounted on 200 mesh copper grids with carbon/formvar films.
Immunolabelling procedure
For negative staining immunolabelling, 400 mesh gold grids with carbon/butvar films were glow-discharged, floated on 0.25% poly-L-lysine (M r 175000, P1399, Sigma) in distilled water for 10 rain, stream-washed in distilled water and airdried. For BA cultures growth was harvested into approx. 2 ml of BSA/PBSA. Broth cultures were spun at 3000 x g for 10 min and the pellet re-suspended in BSA/PBSA. Prepared grids were floated on the bacterial suspensions for 2 min, blotted and transferred to 20 /xl drops of BSA/PBSA for 30 min, incubated on drops of diluted MAbs for 60 min at RT, washed on 3 separate drops of BSA/PBSA for 5 min and transferred to either the 8 nm or 20 nm protein A/gold (PA/Au) probe diluted in BSA/PBSA, for 60 rain at RT. The grids were floated on 3% glutaraldehyde in 0.1 M phosphate buffer pH 7.4 for 30 rain, washed on 5 separate drops of distilled water before negatively staining with 1% potassium phosphotungstate pH 6.5.
In double-labelling experiments, the first-stage P3.15 MAb was probed with 8 nm PA/Au and blocked with 100/tg/ml protein A in BSA/PBSA, followed by the second-stage PI. 16 MAb probed with 20 nm PA/Au. Control grids were incubated with an unrelated mouse ascites IgG MAb to a glycoprotein of Herpes simplex virus type I or the antibody omitted. For double-labelling experiments, the second-stage antibody was omitted but the second-stage PA/Au probe retained.
In labelling experiments on mounted ultrathin Lowicryl resin sections, a similar procedure was adopted.
The CSF and the frozen BA grown cells were thawed rapidly and pre-treated grids pre-incubated on 5% complement-depleted normal rabbit serum in PBSA for 30 min. Fresh BA growth suspended in BSA/PBSA was treated similarly. After incubation with MAbs as above, the grids were floated on drops of 20 nm RAMIgG/Au and 20 nm RAHuIgG, IgA or IgM/Au diluted 1 in 5 in BSA/PBSA for 1 h at RT. Grids were washed, fixed and negatively stained as above, and examined in a Philips EM300 electron microscope.
Control grids were treated as above. To check the specificity of the RAHuIgG, A and M/Au probes, a blocking incubation step of 1 h at RT using a cocktail of the unbound antibodies was included after the initial MAb reaction and before exposure to the relevant antibody/gold probes. 
RESULTS
I. In vitro cultures
Each of the P3.15 MAbs labelled intracellularly as well as on and in the cell wall in ultrathin sections of a BA culture of strain 70942. The two Fig. 1 ) using either an 8 nm or 20 nm gold probe, although there was a trend towards higher density labelling using the 8 nm probe. a h Such variation was less evident on attached or free cell wall blebs. A similar labelling pattern was seen with strain R/P/87 which had been subjected to a freeze-thaw cycle in liquid nitrogen. Broth grown organisms of strain 70942 which were reacted with one P3.15 MAb or one Pl. 16 MAb showed variation between cells, with a trend of increased labelling with time (Table 1 ). In double labelling experiments, all cells labelled with both MAbs but in varying ratios and to varying degrees (Fig. 2a,b) , reflecting the labelling pattern seen with either MAb alone. In contrast, some cell wall blebs were recognised by only one MAb.
Cerebrospinal fluid
On CSF-derived organisms the mean density of labelling of the Pl.16 epitope was similar and that of the P3.15 epitope very low compared with fresh or freeze-thawed cultured organisms (Figs. 3 and  4, respectively) . In contrast with in vitro grown organisms, however, no cell-to-cell variation of label was seen on 23 CSF-derived organisms examined for each epitope.
In double labelling experiments where each epitope was probed with an 8 nm gold probe together with 20 nm RAHulgG, IgA or IgM/Au, the labelling density of the Pl.16 epitope was higher with the 8 nm gold probe (Fig. 5a ) than a 20 nm gold probe used alone (Fig. 3a) ; the labelling of the P3.15 epitope was similar with either probe (Fig.  5b and 4a) . There was heavy labelling using RAHuIgG/Au (Fig. 5) gonorrhoea [4] . Unlike the findings with protein 1 but similar to those with H8 [4] cells showing little labelling could have adjacent cell wall blebs which were heavily labelled.
Cell-to-cell variation could result from varying expression of either the relevant epitope or whole protein. Alternatively, steric hindrance by other surface molecules could impede the accessibility of the epitope to the MAb or the MAb to the gold probe. To explore this latter possibility, smaller gold probes were used. Although there was greater labelling with the smaller probe, implying that inaccessibility to the probe plays some part, cellto-cell variation was still apparent.
Structures which could generate steric hindrance include other OMPs or LOSs. In this study, double labelling experiments with the serotype and subserotype MAbs showed independent variation suggesting that these components of the OMPs may not be involved. Poolman et al. [8] used IGEM to demonstrate that Class 2 protein (P2) of a serotype 2b strain of N. meningitidis showed diminished labelling of stationary compared with log phase cells, possibly relating to increasing molecular weight of LOS over time. This observation is at variance with the increased labelling of the equivalent Class 3 protein (P3) with time reported here. However, we have no information of changes in LOS, though these studies are in progress.
In contrast to in vitro grown organisms cellto-cell variation was not seen in organisms present in the CSF, though this may reflect the low numbers of cells present. The low level of labelling of the porin protein epitope (P3.15) on CSF-derived organisms may be due to steric hindrance or may truly reflect diminished expression of this epitope in vivo, as seen with urinary tract coliforms [16] . Such an occurrence in meningococci has important implications for vaccine development.
An alternative explanation for diminished labelling may be masking by host immunoglobulins. IgA was not found on organisms from the CSF but this may be because the Fc-specific IgA gold probe would not detect IgAase-cleaved IgA molecules which may result from the IgAse activity of N. meningitidis [17] . IgG was detected on these organisms; this may be a specific reaction but specific antibodies in the CSF increase only late in the duration of the disease [18] and a similar reduction in labelling was not apparent for the P1. 16 epitope.
These studies demonstrate that while the cellto-cell phenotypic variation seen in gonococci in vitro is also seen with meningococci, additional phenomena, which have important implications, are seen in vivo. In the absence of relevant animal models, IGEM of meningococci directly from the CSF provides an important tool with which to investigate potentially protective antigens.
